Taku Kobayashi

62PUBLICATIONS
253CO-AUTHORS
GlycoconjugatesImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Other Asian languages (excl. South-East Asian)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Sep 28, 2026
Effectiveness, safety, and clinical outcomes of treatment with the oral α4-integrin antagonist carotegrast methyl in patients with active ulcerative colitis: a multicenter observational study (CANAL study).

|Sep 08, 2026
Association Between Bowel Urgency and Intestinal Ultrasound Parameters in Ulcerative Colitis: Insights Into Transmural Inflammation and Symptom Pathophysiology.

|Aug 30, 2026
Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial.

|Jun 05, 2026
Distinct predictive factors for acute severe ulcerative colitis in East Asian and Western populations.

|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

|May 12, 2026
Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease.

Pageof 11

Frequent Collaborators

11 joint publications

Shintaro Sagami

9 joint publications

Toshifumi Hibi

9 joint publications

Tadakazu Hisamatsu

7 joint publications

Kunio Asonuma